Skip to Content
Merck
All Photos(1)

Key Documents

P-073

Supelco

Pentazocine solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C19H27NO
CAS Number:
Molecular Weight:
285.42
EC Number:
UNSPSC Code:
41116107
NACRES:
NA.24

grade

certified reference material

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal)

concentration

1.0 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

forensics and toxicology

format

single component solution

storage temp.

2-8°C

SMILES string

O=C(C1=C2C(NC(CCOCCC(O)=O)=O)=CC=C1)N([C@H]3CCC(NC3=O)=O)C2=O.O=C(C4=C5C(NC(CCOCCC(O)=O)=O)=CC=C4)N([C@H]6CCC(NC6=O)=O)C5=O

InChI

1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3

InChI key

VOKSWYLNZZRQPF-UHFFFAOYSA-N

Gene Information

human ... SIGMAR1(10280)

General description

A Certified Spiking Solution® applicable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications such as pain prescription monitoring, urine drug testing, forensic analysis, clinical toxicology, or pharmaceutical research. Pentazocine is a synthetic opioid analgesic used for treatment of moderate to severe pain. This painkiller is formulated in combination with naloxone or as a single agent under the trade names Talwin® and Talwin® NX, respectively.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Talwin is a registered trademark of Hospira, Inc.

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Target Organs

Eyes

Storage Class Code

3 - Flammable liquids

WGK

WGK 1

Flash Point(F)

49.5 °F - closed cup

Flash Point(C)

9.7 °C - closed cup


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Robert R Luedtke et al.
Brain research, 1441, 17-26 (2012-01-31)
We previously reported that the antipsychotic drug haloperidol, a multifunctional D2-like dopamine and sigma receptor subtype antagonist, has neuroprotective properties. In this study we further examined the association between neuroprotection and receptor antagonism by evaluating a panel of novel compounds
Christopher D King et al.
Pain, 154(3), 476-483 (2013-02-27)
A number of laboratory studies have confirmed the efficacy of opioid medication in reducing pain generated by a number of psychophysical modalities. However, one implicit assumption of clinical and experimental pain testing of analgesics is that the analgesic response is
Hideharu Hagiya et al.
Internal medicine (Tokyo, Japan), 52(3), 397-402 (2013-02-02)
An 88-year-old man died of streptococcal toxic shock syndrome due to a group G streptococcus infection that was possibly caused by an intramuscular injection given 30 hours earlier in his right deltoid muscle. The causative pathogen was later identified to
Hiroshi Oyake et al.
Masui. The Japanese journal of anesthesiology, 60(10), 1128-1134 (2011-11-25)
The effect of pentazocine on the bispectral index (BIS) has not been reported. In this study, we have examined whether pentazocine alters the bispectral index during nitrous oxide-sevoflurane anesthesia. Thirty surgical patients were enrolled in this double-blind, randomized study. Anesthesia
Leon F Tseng et al.
Life sciences, 89(23-24), 875-877 (2011-10-13)
We have previously demonstrated that pretreatment with (+)-morphine given intrathecally attenuates the intrathecal (-)-morphine-produced tail-flick inhibition. The phenomenon has been defined as antianalgesia against (-)-morphine-produced analgesia. Present experiments were then undertaken to determine if the antianalgesic effect induced by (+)-morphine

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service